JP2025502254A5 - - Google Patents

Info

Publication number
JP2025502254A5
JP2025502254A5 JP2024541957A JP2024541957A JP2025502254A5 JP 2025502254 A5 JP2025502254 A5 JP 2025502254A5 JP 2024541957 A JP2024541957 A JP 2024541957A JP 2024541957 A JP2024541957 A JP 2024541957A JP 2025502254 A5 JP2025502254 A5 JP 2025502254A5
Authority
JP
Japan
Prior art keywords
compound according
disease
compound
alkyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024541957A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025502254A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/010783 external-priority patent/WO2023137166A1/en
Publication of JP2025502254A publication Critical patent/JP2025502254A/ja
Publication of JP2025502254A5 publication Critical patent/JP2025502254A5/ja
Pending legal-status Critical Current

Links

JP2024541957A 2022-01-14 2023-01-13 補体因子の阻害剤及びその使用 Pending JP2025502254A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263299712P 2022-01-14 2022-01-14
US63/299,712 2022-01-14
PCT/US2023/010783 WO2023137166A1 (en) 2022-01-14 2023-01-13 Inhibitors of complement factors and uses thereof

Publications (2)

Publication Number Publication Date
JP2025502254A JP2025502254A (ja) 2025-01-24
JP2025502254A5 true JP2025502254A5 (https=) 2026-01-21

Family

ID=87279676

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024541957A Pending JP2025502254A (ja) 2022-01-14 2023-01-13 補体因子の阻害剤及びその使用

Country Status (10)

Country Link
US (1) US12522619B2 (https=)
EP (1) EP4463462A4 (https=)
JP (1) JP2025502254A (https=)
KR (1) KR20240135818A (https=)
CN (1) CN118715231A (https=)
AU (1) AU2023207988A1 (https=)
CA (1) CA3248405A1 (https=)
IL (1) IL314164A (https=)
MX (1) MX2024008710A (https=)
WO (1) WO2023137166A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022020244A1 (en) 2020-07-20 2022-01-27 Annexon, Inc. Inhibitors of complement factors and uses thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965583A (en) 1997-04-24 1999-10-12 Ortho-Mcneil Pharmaceutical, Inc. Substituted imidazoles useful in the treatment of inflammatory disease
EP1971664B1 (en) 2006-01-13 2015-09-09 LG Chem, Ltd. Emitting materials and organic light emitting device using the same
KR20100031723A (ko) * 2007-07-07 2010-03-24 이데미쓰 고산 가부시키가이샤 크리센 유도체 및 이를 이용한 유기 전계 발광 소자
KR101233377B1 (ko) * 2008-12-30 2013-02-18 제일모직주식회사 신규한 유기광전소자용 화합물 및 이를 포함하는 유기광전소자
WO2013049332A1 (en) * 2011-09-29 2013-04-04 Infinity Pharmaceuticals, Inc. Inhibitors of monoacylglycerol lipase and methods of their use
WO2015003146A1 (en) 2013-07-03 2015-01-08 Georgetown University Boronic acid derivatives of resveratrol for activating deacetylase enzymes
DK3019240T3 (da) 2013-07-09 2024-06-03 Annexon Inc Anti-komplementfaktor C1Q antistoffer og anvendelser deraf
TWI532741B (zh) * 2013-09-04 2016-05-11 喜星素材股份有限公司 含吡唑之多環化合物及使用其之有機發光裝置
KR101635154B1 (ko) 2014-08-28 2016-06-30 (주)더블유에스 피리딜기가 결합된 트리아진 유도체 및 이를 포함한 유기 전계발광 소자
KR102233296B1 (ko) 2014-11-18 2021-03-29 덕산네오룩스 주식회사 유기전기 소자용 화합물, 이를 이용한 유기전기소자 및 그 전자 장치
AR103397A1 (es) 2015-01-13 2017-05-10 Syngenta Participations Ag Oxoborazoles microbicidas
US10111885B2 (en) 2015-03-13 2018-10-30 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases
KR101981245B1 (ko) * 2015-10-27 2019-05-22 주식회사 엘지화학 고리 화합물 및 이를 포함하는 유기 발광 소자
KR101806464B1 (ko) 2015-11-19 2017-12-07 (주)랩토 피리딜기가 결합된 피리미딘 유도체 및 이를 이용한 유기 전계 발광 소자
KR102496411B1 (ko) * 2016-01-06 2023-02-06 덕산네오룩스 주식회사 유기전기 소자용 화합물, 이를 이용한 유기전기소자 및 그 전자 장치
US10646488B2 (en) * 2016-07-13 2020-05-12 Araxes Pharma Llc Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof
WO2019240471A1 (ko) 2018-06-11 2019-12-19 주식회사 엘지화학 헤테로고리 화합물 및 이를 포함하는 유기 발광 소자
WO2020032428A1 (ko) 2018-08-09 2020-02-13 덕산네오룩스 주식회사 유기전기 소자용 화합물을 포함하는 유기전기소자 및 그 전자 장치
CN109574917B (zh) 2018-12-03 2020-12-08 武汉尚赛光电科技有限公司 一种芴酮衍生物及其制备和应用
CN111087387B (zh) 2019-12-26 2022-04-29 厦门天马微电子有限公司 一种有机化合物、显示面板及显示装置
CN111423390A (zh) * 2020-03-30 2020-07-17 北京燕化集联光电技术有限公司 一种新型结构化合物及其应用
CN111662309B (zh) * 2020-07-10 2021-11-09 北京燕化集联光电技术有限公司 一种多杂环结构化合物及其应用
WO2022020244A1 (en) 2020-07-20 2022-01-27 Annexon, Inc. Inhibitors of complement factors and uses thereof
CN113045585A (zh) * 2021-03-16 2021-06-29 吉林奥来德光电材料股份有限公司 一种有机稠环化合物及其制备方法和应用
CN113831332B (zh) * 2021-10-29 2024-06-18 长春海谱润斯科技股份有限公司 一种含氮杂环衍生物及其在有机电致发光器件中的应用

Similar Documents

Publication Publication Date Title
JP2023534974A5 (https=)
JP2025504859A5 (https=)
JP2024541929A5 (https=)
FI3215527T3 (fi) Humanisoituja anti-komplementtitekijä c1q -vasta-aineita ja niiden käyttöjä
JP2025502254A5 (https=)
MX2010013058A (es) Derivado de benceno o tiofeno y su uso como inhibidor de proteina 1 de adhesion vascular.
AU2020299526B2 (en) Bax inhibitors and uses thereof
US20190209605A1 (en) Cyclodextrin based polymers, methods, compositions and applications thereof
JP7340023B2 (ja) テトラゾロン置換ステロイド及びその使用
US11897876B2 (en) Isoxazolidines as RIPK1 inhibitors and use thereof
ES2749657T3 (es) Derivados de O-alquil-bencilidenguanidina y su uso terapéutico para el tratamiento de trastornos asociados a una acumulación de proteínas mal plegadas
JPH08509969A (ja) 新規ルパン誘導体、その製造およびそれを含む医薬組成物
US20220056045A1 (en) Solid forms of ceftolozane and processes for preparing
CA2493751A1 (fr) Derives d'arylimidazoles et leur utilisation en tant qu'inhibiteurs de no synthases et en tant que modulateurs des canaux sodiques
US12522619B2 (en) Inhibitors of complement factors and uses thereof
CA2433582A1 (en) Peptides having inhibiting activity on the production of nitric oxide
US12473276B2 (en) Compound having neuroprotective effect, preparation method therefor and use thereof
WO2026083346A1 (en) Dpp1 inhibitors with cyclic or linear linkers and uses thereof
US20250368655A1 (en) Small molecule inhibitors of bcr-abl
WO2023009585A2 (en) Transthyretin stabilizing compounds
WO2024040155A1 (en) Isoxazolidines as ripk1 inhibitors and use thereof
CN118852111A (zh) 一种哌啶基吲哚化合物的晶型及其制备方法
EA043363B1 (ru) Ингибиторы rho-ассоциированной суперспираль содержащей протеинкиназы
HK40010191A (en) Cyclodextrin based polymers, methods, compositions and applications thereof